These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25203481)

  • 1. Botox enhancing eyebrow elevation in external ophthalmoplegia ptosis.
    Putterman AM
    Ophthalmic Plast Reconstr Surg; 2014; 30(5):444-5. PubMed ID: 25203481
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum Toxin as an Alternative to Treat the Spasm of the Near Reflex.
    Laria C; Merino-Suárez ML; Piñero DP; Gómez-Hurtado A; Pérez-Cambrodí RJ
    Semin Ophthalmol; 2015; 30(5-6):393-6. PubMed ID: 24809739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of Botox injections for chronic temporomandibular disorders: do we understand how Botox works on muscle, pain, and the brain?
    Connelly ST; Myung J; Gupta R; Tartaglia GM; Gizdulich A; Yang J; Silva R
    Int J Oral Maxillofac Surg; 2017 Mar; 46(3):322-327. PubMed ID: 27908491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective and Objective Measures in the Treatment of Hemifacial Spasm With OnabotulinumtoxinA.
    Chundury RV; D'Angelo AS; Couch SM; Holds JB
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):133-7. PubMed ID: 25811161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of onabotulinum toxin a injection to the central upper eyelid and eyebrow regions.
    Huang L; Costin BR; Sakolsatayadorn N; Perry JD
    Ophthalmic Plast Reconstr Surg; 2014; 30(5):377-80. PubMed ID: 24777259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
    Yücel OE; Artürk N
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining treatment of gummy smile with Botox--a report of three cases.
    Singh H; Srivastava D; Sharma P; Kapoor P; Roy P
    Int J Orthod Milwaukee; 2014; 25(4):63-6. PubMed ID: 25745713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target.
    Wei LA; Diels J; Lucarelli MJ
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral ptosis with ophthalmoplegia in a 72-year-old woman with diabetes.
    Nakai A; Nishida Y; Kondou K; Mokuno T; Oda N; Sawai Y; Mano T; Kotake M; Masunaga R; Yamamoto H
    Diabetes Res; 1994; 26(2):89-92. PubMed ID: 7554729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing ptosis after botulinum treatment.
    Scott AB
    Ophthalmic Plast Reconstr Surg; 1997 Jun; 13(2):81-3. PubMed ID: 9185190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botox: shaken, not stirred.
    Kazim NA; Black EH
    Ophthalmic Plast Reconstr Surg; 2008; 24(1):10-2. PubMed ID: 18209633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: "Botulinum toxin type A for dysthyroid upper eyelid retraction".
    Fay A
    Ophthalmic Plast Reconstr Surg; 2005 Jan; 21(1):81; author reply 81-2. PubMed ID: 15677964
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis.
    Ellis MF; Daniell M
    Clin Exp Ophthalmol; 2001 Dec; 29(6):394-9. PubMed ID: 11778810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Ophthalmoplegia and Recurrent Ptosis After Ptosis Repair Surgery.
    Li E; Kostina Y; Lesser RL
    JAMA Ophthalmol; 2018 Aug; 136(8):952-953. PubMed ID: 29879280
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of botulinum toxin in the treatment of intermittent exotropia.
    Etezad Razavi M; Sharifi M; Armanfar F
    Strabismus; 2014 Dec; 22(4):176-81. PubMed ID: 25313677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical use of frontalis muscle and the possible role of botulinum a toxin in permanent motor relearning.
    Ben Simon GJ; Blaydon SM; Schwarcz RM; Nakra T; Goldberg RA; McCann JD
    Ophthalmology; 2005 May; 112(5):918-22. PubMed ID: 15878076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.
    McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abobotulinum toxin A (Dysport) and botulinum toxin type A (Botox) for purposeful induction of eyelid ptosis.
    Reddy UP; Woodward JA
    Ophthalmic Plast Reconstr Surg; 2010; 26(6):489-91. PubMed ID: 20724861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin injection for production of ptosis].
    Merté RL; Lanzl IM
    Ophthalmologe; 2007 Sep; 104(9):767-70. PubMed ID: 17846779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum A exotoxin in clinical ophthalmology.
    Carruthers JD; Carruthers A
    Can J Ophthalmol; 1996 Dec; 31(7):389-400. PubMed ID: 8971462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.